
Pawan Nahar is a financial journalist with over a decade in journalism, saying good morning to BSE's Sensex and NSE Nifty50. Keen follower of IPOs, he also tracks cryptos, and personal finance — covering everything one can invest in. Known for due diligence and fluent Hindi, he blends insight with engaging storytelling. A YouTube learner beyond work, he enjoys cooking, poetry, traveling, and gaming.

Wakefit Innovations sold its shares in the price band of Rs 185-195 apiece, applied for a minimum of 76 shares and its multiples to raise Rs 1,288.89 crore between December 8-10.

Corona Remedies sold its shares in the price band of Rs 1,008-1,062 apiece, applied for a minimum of 14 shares and its multiples to raise Rs 655.37 crore between December 8-10.

Park Medi World sold its shares in the price band of Rs 154-162 apiece, which could be applied for a minimum of 92 shares and its multiples between December 10-12.

Nephrocare Health Services sold its shares in the price band of Rs 438-460 apiece, which could be applied for a minimum of 32 shares and its multiples between December 10-12.

Nifty futures on the NSE International Exchange traded 90.40 points, or 0.35 per cent, down at 26,055, hinting at a positive start for the domestic market on Monday.

Stocks including Wakefit, Wipro, BEL, Paytm, Corona Remedies, Dr Reddy's, Auro Pharma, KEC International and more will be in the spotlight on Monday, December 15.

Two new companies, namely- Wakefit Innovations and Corona Remedies- are set to make their Dalal Street debut on Monday, December 15 on BSE and NSE.

SMC Global said that Mphasis is attempting a constructive turnaround on the daily charts, supported by an emerging strong support near the demand zone where stock has built a triple bottom pattern.

IPO of ICICI Prudential AMC is set to open for bidding on Friday, December 12 as the asset management player has reserved 24,48,649 equity shares for its eligible shareholders of ICICI Bank.

BHEL share price: Domestic brokerage firms are divided on Bharat Heavy Electricals with some suggesting a strong upside in the stock citing improving fundamentals, while other see downside.





